Path A: Using Ready-to-Use Options (Pen, Syringe, Tablet)

Overview

Path A uses GLP-1 RA medication in formats that need almost no preparation: single-use pens (for example, Tizaro), pre-filled syringes (Semaglo OB), or oral tablets (Rybelsus®). These items are often imported through gray-market channels.

Specific Risks & Considerations

warning

Shipping and customs: Parcels can be delayed, lost, or seized (If it's for personal use, highly unlikely).

Limited support: If the pen or syringe malfunctions, getting a replacement or refund is unlikely.

Lack of medical oversight: Using any GLP-1 without a clinician means side effects and drug interactions may go unnoticed.

See Risks & Side Effects.